HCN Channel Targets for Novel Antidepressant Treatment

P 107: P2x7 Receptors: as a Novel Targets for the Treatment of Neuroinflammation

P2x7 receptors are Purineric receptors that are extracellular ATP-gated ion channel. These receptors require high dose or prolonged exposure to ATP for initial activation. The Activation of these receptors facilitates the formation of inflammasome which activates caspase 1. The P20 and P10 subunits of caspase 1 form active enzyme that then releases active interleukin (IL)-1 β and IL-18, tu...

S4 Movement in a Mammalian HCN Channel

Hyperpolarization-activated, cyclic nucleotide-gated ion channels (HCN) mediate an inward cation current that contributes to spontaneous rhythmic firing activity in the heart and the brain. HCN channels share sequence homology with depolarization-activated Kv channels, including six transmembrane domains and a positively charged S4 segment. S4 has been shown to function as the voltage sensor an...

micrornas: promising potential targets for cancer treatment

p 107: p2x7 receptors: as a novel targets for the treatment of neuroinflammation

p2x7 receptors are purineric receptors that are extracellular atp-gated ion channel. these receptors require high dose or prolonged exposure to atp for initial activation. the activation of these receptors facilitates the formation of inflammasome which activates caspase 1. the p20 and p10 subunits of caspase 1 form active enzyme that then releases active interleukin (il)-1 β and il-18, tumor n...

Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?

Clonidine, like many other imidazoline drugs, is usually thought of as a selective α2-adrenergic agonist and is approved for use as a centrally acting antihypertensive agent. In addition, clonidine is prescribed off-label to treat some cases of Tourette’s syndrome, and it may also have a role in the treatment of other psychiatric conditions, including obsessive–compulsive disorders, panic state...